Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection
• Researchers are investigating whether the four-component meningococcal serogroup B vaccine (4CMenB) can prevent infections caused by Neisseria gonorrhoeae, as no licensed vaccines currently exist for the disease. • The study, supported by GSK and the Australian National Health and Medical Research Council (grant GNT1182443), relies on observational data to determine if the vaccine provides cross-protection. • This research is critical because gonorrhea is a widespread sexually transmitted infection with increasing antibiotic resistance, making a preventative vaccine a global health priority.
nejm.org



